Nota: La página que ha solicitado no está en su idioma predeterminado. Usted está usando nuestra plataforma en otro idioma ahora.
In financial year 2019, Sonic Healthcare Limited recognized net profit after tax of over 549 million Australian dollars. In addition to being one of the largest pathology and laboratory medicine companies in the world, Sonic Healthcare also provides general practice, radiology, occupational medicine, and corporate medical services across Australia.
Net profit after tax (NPAT) of Sonic Healthcare Limited in Australia from financial year 2015 to 2019 (in million Australian dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Revenue of Sonic Healthcare Limited FY 2015-2023
- Premium Statistic EBITDA of Sonic Healthcare Limited FY 2015-2023
- Premium Statistic Total assets of Sonic Healthcare Limited Australia FY 2015-2019
- Premium Statistic Total liabilities of Sonic Healthcare Limited Australia FY 2015-2019
- Premium Statistic Net assets of Sonic Healthcare Limited Australia FY 2015-2019
- Premium Statistic Net interest-bearing debt of Sonic Healthcare Limited Australia FY 2015-2019
- Premium Statistic Gearing ratio of Sonic Healthcare Limited Australia FY 2015-2019
- Premium Statistic Return on equity of Sonic Healthcare Limited Australia FY 2015-2019
- Premium Statistic Net cash flow from operations of Sonic Healthcare Limited Australia FY 2015-2019
- Basic Statistic Hungary: protective or corrective spectacles and goggles import value 2015-2023
About the region
10
- Premium Statistic Value of monthly imports of medical and pharmaceutical products Australia 2020-2024
- Premium Statistic Total operating revenue of CSL Ltd FY 2015-2023
- Premium Statistic Net profit of CSL Limited FY 2015-2023
- Premium Statistic R&D expenditure of CSL Limited FY 2015-2023
- Premium Statistic Number of GPs in Australia 2019, by state and territory
- Premium Statistic Total current assets of CSL Ltd Australia FY 2014-2019
- Premium Statistic Total non current assets of CSL Ltd Australia FY 2014-2019
- Premium Statistic Total current liabilities of CSL Ltd Australia FY 2014-2019
- Premium Statistic Total non current liabilities of CSL Ltd Australia FY 2014-2019
- Premium Statistic Total equity of CSL Ltd Australia FY 2014-2019
Other regions
10
- Premium Statistic Total addressable CRO market worldwide in 2018, by function
- Premium Statistic Percentage of people trusting or not artificial intelligence in France 2019
- Basic Statistic Most important health issues facing the U.S. according to U.S. adults 2023
- Premium Statistic Number of new pharmaceutical drug approvals in South Korea 2014 by therapeutic area
- Premium Statistic Research and development expenditure by DRDO in India FY 2011-2015
- Premium Statistic Trust in scientists in the United Kingdom in 2018, by gender
- Premium Statistic Trust in scientists in European nations in 2018
- Premium Statistic Established doctors in Germany in 2022, by area of expertise and age group
- Premium Statistic Trust in science and research in Flanders (Belgium) 2021
- Premium Statistic Funds raised by the Italian Association for Cancer Research 2022, by action
Related statistics
4
- Premium Statistic Medical and other health care services industry employees New Zealand 2020, by region
- Premium Statistic Earnings per share of CSL Ltd Australia FY 2015-2019
- Premium Statistic Share of visits to a GP in Australia FY 2018, by age
- Premium Statistic Concern for health system New Zealand 2018
Further related statistics
9
- MorphoSys' research & development expenditure 2006-2023
- Merck & Co - expenditure on research and development 2006-2023
- AstraZeneca's expenditure on research and development 2006-2023
- Primary reason for receiving a massage in the U.S. 2015
- Medicinal market growth worldwide including rebates 2009-2018
- Expenditure worldwide on diabetes by market 2013-2018
- Cost savings through urgent care vs emergency department 2012
- Portion distortion over the last 20 years in the U.S. for selected foods 2011
- R&D expenditure in U.S. biotechnology 2009-2010 by type
Further Content: You might find this interesting as well
Statistics
- MorphoSys' research & development expenditure 2006-2023
- Merck & Co - expenditure on research and development 2006-2023
- AstraZeneca's expenditure on research and development 2006-2023
- Primary reason for receiving a massage in the U.S. 2015
- Medicinal market growth worldwide including rebates 2009-2018
- Expenditure worldwide on diabetes by market 2013-2018
- Cost savings through urgent care vs emergency department 2012
- Portion distortion over the last 20 years in the U.S. for selected foods 2011
- R&D expenditure in U.S. biotechnology 2009-2010 by type
Sonic Healthcare. (October 18, 2019). Net profit after tax (NPAT) of Sonic Healthcare Limited in Australia from financial year 2015 to 2019 (in million Australian dollars) [Graph]. In Statista. Retrieved June 05, 2024, from https://www.statista.com/statistics/1066784/australia-sonic-healthcare-ltd-net-profit-after-tax/
Sonic Healthcare. "Net profit after tax (NPAT) of Sonic Healthcare Limited in Australia from financial year 2015 to 2019 (in million Australian dollars)." Chart. October 18, 2019. Statista. Accessed June 05, 2024. https://www.statista.com/statistics/1066784/australia-sonic-healthcare-ltd-net-profit-after-tax/
Sonic Healthcare. (2019). Net profit after tax (NPAT) of Sonic Healthcare Limited in Australia from financial year 2015 to 2019 (in million Australian dollars). Statista. Statista Inc.. Accessed: June 05, 2024. https://www.statista.com/statistics/1066784/australia-sonic-healthcare-ltd-net-profit-after-tax/
Sonic Healthcare. "Net Profit after Tax (Npat) of Sonic Healthcare Limited in Australia from Financial Year 2015 to 2019 (in Million Australian Dollars)." Statista, Statista Inc., 18 Oct 2019, https://www.statista.com/statistics/1066784/australia-sonic-healthcare-ltd-net-profit-after-tax/
Sonic Healthcare, Net profit after tax (NPAT) of Sonic Healthcare Limited in Australia from financial year 2015 to 2019 (in million Australian dollars) Statista, https://www.statista.com/statistics/1066784/australia-sonic-healthcare-ltd-net-profit-after-tax/ (last visited June 05, 2024)
Net profit after tax (NPAT) of Sonic Healthcare Limited in Australia from financial year 2015 to 2019 (in million Australian dollars) [Graph], Sonic Healthcare, October 18, 2019. [Online]. Available: https://www.statista.com/statistics/1066784/australia-sonic-healthcare-ltd-net-profit-after-tax/